Winnipeg elm tree loss overshoots target: report
The City of Winnipeg marked 6,616 American elm trees for removal last year due to Dutch elm disease, resulting in a 3.4 per cent loss rate — extending beyond the annual average target.
According to an administrative report on the status of Dutch elm disease management in Winnipeg, the city has approximately 194,390 American elms, described as 'the largest American elm population of any North American city.'
The annual average target for the city's loss rate of American elms is listed at two per cent.
Dutch elm disease is a fungal infection that blocks the tree's water-conducting tissues, spread mainly by native elm bark beetles, according to the city's website.
Altogether in 2024, just over 7,000 elms were removed under the Dutch elm disease management program, which includes trees that were tagged during previous years.
The report says that approximately $172 million has been directed to management since the disease was detected in the city 50 years ago to 'slow the spread' and to preserve the elm canopy.
The widespread planting of American elms, 'once a characteristic of many Winnipeg neighbourhoods,' is listed as a contributing factor in the spread of the disease.
City would lose 'almost all' elms by 2045 without management: report
According to the report, the city would lose 'almost all' of its American elms in the next 20 years if Dutch elm disease management were to stop today. Under this scenario, the total removal cost would be approximately $200 million, without adjusting for inflation.
The city said though the average annual loss rate in Winnipeg has 'varied considerably over time,' the loss rate over the past five years has been approximately 2.2 per cent in parks and on boulevards.
The five-year average annual loss rate for elms on all property types is 3.6 per cent.
The city's Dutch elm disease management program includes removal of diseased and declining trees, firewood monitoring and disposal, elm bark beetle control, reforestation and public education.
The report said, 'The City of Winnipeg program has been the most successful (Dutch elm disease) management program in North America.'
Nearly 6,500 trees were planted last year on boulevards and in parks as part of reforestation efforts, according to the report.
Elm trees currently represent 22 per cent of the city's public tree inventory.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
National Post
34 minutes ago
- National Post
Synaptive Medical Secures Strategic Investment to Accelerate Growth and Innovation
Article content MedTech leader emerges from restructuring with renewed momentum and an unwavering focus on transformative surgical care. Article content TORONTO — Synaptive Medical, a global medical technology innovator, today announced the successful completion of a strategic restructuring and the closing of a significant new private investment. This milestone marks a pivotal new chapter for the company—one that strengthens its mission to revolutionize neurosurgical care in close collaboration with clinicians worldwide. Article content 'We remain deeply committed to investing in the people, tools, and technologies that drive progress in surgical planning, neuro-navigation, robotic exoscopy, and advanced MRI,' said Cameron Piron, President and Founder of Synaptive Medical. 'From enhancing surgical precision with our integrated robotic and navigation systems to expanding the diagnostic potential of our MRI platforms, Synaptive is redefining the future of surgery—from imaging to intervention.' Article content As part of its transformation, Synaptive is reaffirming its commitment to its comprehensive product portfolio. The company will continue to expand its integrated surgical suite—including Modus X™, Modus Nav™, and Modus Plan™ —alongside its dedicated MRI platform. These advancements are closely aligned with long-standing partnerships at leading hospitals and clinical institutions around the world. Article content Throughout the restructuring, Synaptive maintained uninterrupted customer support while continuing to execute on its innovation roadmap. Recent milestones include major software upgrades across its platforms and the launch of new collaborations with internationally recognized medical centers in the United States and Europe. Article content The newly secured investment will bring the company to profitability and reflects strong confidence in Synaptive's strategic direction and long-term growth. The company has been wholly acquired by a mission-aligned consortium of MedTech executives, clinicians, and experienced investors who bring deep domain expertise and a shared vision for the future of neurosurgical care. Article content 'This investment represents a powerful recommitment to Synaptive's mission: to transform brain health in the 21st century for patients and families in need,' said Dr. Joshua Bernstock, neurosurgeon and incoming board member. 'We're proud to join forces with a team that is not only passionate about elevating the standard of care but also fearless in pushing the boundaries of what's possible in diagnostics and surgical innovation.' Article content This investment represents the first phase of a broader capital initiative, with additional funding expected in the coming weeks to further support Synaptive's growth strategy and accelerate its innovation pipeline. Article content About Synaptive Medical Article content Synaptive Medical Inc. is a Toronto-based global medical technology company dedicated to solving complex challenges in surgery, imaging, and data integration to improve patient outcomes. Its integrated suite of solutions—spanning MRI, surgical planning, navigation, and robotic visualization—delivers intelligent, patient-centric technology that enhances clinical decision-making and efficiency across every stage of neurosurgical care. Article content Article content Article content Article content Article content Contacts Article content Media: Article content Article content Article content
Globe and Mail
an hour ago
- Globe and Mail
Got $200? 2 Biotech Stocks to Buy and Hold Forever
Some potential investors hesitate to get started on building an investment portfolio because they think they need thousands of dollars to grow wealth. But I've got good news for them and for you: You don't have to start out with a huge pile of cash to invest in stocks that may significantly add value to your portfolio over time. In fact, with just $200, you can get in on players that could help you along the path to wealth. The industry of biotech is a great place to look for such stocks since so many of these companies are developing cutting-edge technologies that may lead to high-growth products, and revenue, down the road. Let's consider two that you might buy today -- a few shares of each for a total of $200 -- and hold forever to benefit from lasting growth stories. 1. Viking Therapeutics Viking Therapeutics (NASDAQ: VKTX) aims to make its mark in one of today's (and tomorrow's) biggest healthcare growth areas: weight loss drugs. The biotech company is developing a dual GIP/GLP-1 receptor agonist, known as VK2735, and has progressed into late-stage clinical trials. The candidate, in injectable form, just launched its phase 3 program and aims to enroll more than 4,000 participants with obesity and more than 1,000 volunteers with obesity and type 2 diabetes. VK2735 works by interacting with hormonal pathways involved in the control of appetite and blood sugar levels, much like the already commercialized Mounjaro and Zepbound, sold by Eli Lilly, and Ozempic and Wegovy, sold by Novo Nordisk. But the fact that similar drugs have reached the market first doesn't mean Viking can't succeed here. Demand for these sorts of products has been so high that it exceeded supply, until Lilly and Novo Nordisk increased manufacturing capacity. So there's plenty of room for a young company like Viking to succeed here too if all continues to go well in clinical trials. Viking also is testing VK2735 in oral form in a phase 2 trial, an important point since oral formulation could make these drugs easier to take, and it involves faster and cheaper manufacturing processes for the company. Data from that trial is expected later this year. Viking stock is known to soar on positive results. It surged more than 120% last year in just one trading session after reporting positive phase 2 data for VK2735. It's since given up the gains, offering investors a solid entry point, but any good news and a possible regulatory nod could prompt the stock to skyrocket. 2. Moderna Moderna (NASDAQ: MRNA) used to be a favorite of investors during the early days of the coronavirus pandemic -- but since, it's had trouble bringing investors back into its potential growth story. The stock has lost more than 90% since its peak back in 2021, and the company has reported decreasing sales because of the drop in demand for its coronavirus vaccine and lower-than-expected sales of its more recently launched respiratory syncytial virus (RSV) vaccine. After Moderna's billions of dollars in revenue and profit just a couple of years ago and recent earnings declines, investors may find it difficult to get excited about Moderna again. But it's important to remember two things: First, it's unfair to compare revenue potential during ordinary times to revenue linked to a pandemic-related product. Those were exceptional times that don't occur often. Second, the approval of Moderna's coronavirus and RSV vaccines show that its technology -- the technology driving the rest of its pipeline -- works. The company now has many late-stage products in the works and aims to launch as many as 10 over the next few years. If Moderna even makes it partially to that goal, its revenue picture a few years from now may look very different from the picture today -- and set the company up for long-term growth. It's too early to predict when the market will recognize this and flock to Moderna shares. But at today's level, the stock offers investors a buying opportunity, making it a great place to park part of your $200 and hold on for the long-term as this growth story develops. Should you invest $1,000 in Viking Therapeutics right now? Before you buy stock in Viking Therapeutics, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Viking Therapeutics wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $713,547!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $966,931!* Now, it's worth noting Stock Advisor 's total average return is1,062% — a market-crushing outperformance compared to177%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 30, 2025
CBC
2 hours ago
- CBC
How St. Michael's Hospital is trying to break the cycle of readmissions for homeless patients
April Aleman tracks the Uber she ordered for her 82-year-old client as it makes its way to a public health building on a quiet street tucked away from the bustle of downtown Toronto. When the vehicle arrives, Aleman unpacks a walker from the trunk and greets the woman with a warm familiarity. She slows her pace to match her client's as they make their way into the clinic and approach the front desk. "Hello, we have a dentist appointment," Aleman tells the receptionist while helping the woman rummage through her purse to find a health card. They sit side-by-side on plastic chairs in a near-empty waiting room, leaning towards each other to complete paperwork on a clipboard. "Do you have an emergency contact you want to put down?" Aleman, a homeless outreach counsellor at St. Michael's Hospital, asks, pen in hand. "No, just you people," her client quips, and they both laugh. Aleman works at the Navigator Program, which helps steer unhoused people through a health-care system that can be especially challenging for patients without a fixed address or means to advocate for themselves. The program was established to break the cycle of hospital readmission and improve health outcomes. Aleman's client said she was admitted to St. Mike's with COVID-19 in late December. When it was time for her discharge on Christmas Day, she was homeless for the first time in her life. She said a family member she was living with had kicked her out of the house. WATCH | 135 unhoused people died in the first 6 months of 2024: 135 homeless deaths reported in Toronto during first half of 2024: report 5 months ago Duration 2:18 A group of Torontonians who are homeless, or have been, are calling for better supports and policies to help people with disabilties. The calls to action come the same week the city released new data about the deadly toll of homelessness. CBC's Sarah MacMillan reports. The navigators took over her case and found her a shelter bed. "I hate to even think about it," she said of what would have happened if Navigator hadn't intervened and she walked out into the bitter cold with nowhere to go. In late January, Aleman helped her secure an apartment in a Toronto Community Housing senior's building. "Everything I've been through … they've been there," said the woman, whom the hospital asked not to be named to respect the privacy of patient health information. Once their hospital treatment ends, patients without housing are discharged back onto the streets, often without a phone, family doctor, health card or shelter. Many return to hospital with worsened health conditions and the cycle continues. Navigator started at Toronto's St. Michael's Hospital in 2019, and expanded to Vancouver's St. Paul's Hospital in 2023, collectively serving more than 1,000 patients since then. One of the first clients from the Vancouver hospital was a woman who landed in the emergency department about 26 times in two months. "Then I started working with her," said Alex MacKinnon, an outreach navigator at St. Paul's. WATCH | More than 80,000 people were homeless in Ontario last year: More than 80,000 people in Ontario were homeless in 2024, new report finds 6 months ago Duration 5:00 More than 80,000 people in Ontario were homeless last year, a new report from the province's municipalities shows, in what is the clearest picture of the issue to date. MacKinnon said she helped the patient find housing and saw concrete change, despite the ongoing management of chronic illnesses. "Having checked back in on her ED rates, they went down significantly," she said. Dr. Stephen Hwang created the program at St. Mike's after examining readmission rates among homeless patients admitted to internal medicine between November 2017 and 2018. He found that 27 per cent of 129 patients returned within 90 days. Roughly a third of participants were readmitted for an identical diagnosis as their initial admission. It's like having a "super advocate," said Hwang. A randomized controlled trial is underway to establish whether the program cuts down on return hospital visits. The trial, funded by a Canadian Institutes of Health Research foundation grant, involves 656 people experiencing homelessness. WATCH | Inside Ontario's legislative plan to dismantle encampments: 'Enough is enough': Ford details legislation aimed at dismantling homeless encampments 7 months ago Duration 2:02 Premier Doug Ford's government is cracking down on encampments, unveiling a new bill that would impose stiffer penalties for trespassing and public drug use. Hwang said there are already striking indicators that the approach works, such as the fact 67 per cent of Navigator patients who needed a family doctor obtained one through the program. Navigator has three outreach workers at St. Mike's and one at St. Paul's, including Aleman in Toronto and MacKinnon in Vancouver. On average, they each see 15 patients at a time for about 90 days. In Toronto it's funded by St. Michael's Hospital Foundation while the Vancouver pilot is funded by Staples Canada. Navigators bring patients coffee, toothbrushes and fresh socks when they're admitted to hospital. These small acts helps build strong relationships between outreach counsellors and their clients, said Dr. Anita Palepu, an internal medicine physician at St. Paul's. "It's not just a physical poverty. In some cases, it's also deep social poverty and isolation," said Palepu. The hope is that after three months patients stand on more stable ground with a roof over their head, a family doctor and government benefits. Though the Navigator office door always stays open. One morning in late May, Fred Ellerington, another Toronto navigator, was alerted that one of his patients was in the emergency department. Right away, one of his colleagues left their shared office on the general internal medicine floor to check on them. "We're embedded," Ellerington said of the immediate access hospital-based navigators have to patients and their electronic medical records. Ellerington said the patient had cleared standard health tests but his colleague could tell something was off because the patient's behaviour was odd compared to a visit a week earlier. Ellerington said they encouraged a closer look, suspecting a neurological problem. "They just don't have that relationship with the patient," Ellerington said. WATCH | The new program helping unhoused people: A look at Toronto's newest supportive housing initiative for unhoused people 9 months ago Duration 2:20 Toronto is getting new supportive housing that will have doctors on site, mental health resources, as well as food programs. As CBC's Ali Chiassion reports, it's aimed at helping Toronto's unhoused population get back on their feet. While the program's primary goal is improving health outcomes, Ellerington said cutting return visits can also save money and hospital beds. Hwang said he is working to launch the program at the University of Montreal Hospital Centre later this year and wants to see it in more hospitals across the country. Long-term, he said he wants policies and programs to address the root causes of homelessness, including making housing and mental health supports more affordable. "But in the meantime, it's just really important that we serve the people who are right before us in our midst, who have urgent, severe health problems, and who end up literally on the doorstep of the hospital."
